Carlos Javier Chaccour Diaz-rekin lankidetzan egindako argitalpenak (7)

2021

  1. The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial

    EClinicalMedicine, Vol. 32

2020

  1. Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats

    Scientific Reports, Vol. 10, Núm. 1

  2. The sars-cov-2 ivermectin navarra-isglobal trial (saint) to evaluate the potential of ivermectin to reduce covid-19 transmission in low risk, non-severe covid-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial

    Trials, Vol. 21, Núm. 1

2018

  1. Targeting cattle for malaria elimination: Marked reduction of Anopheles arabiensis survival for over six months using a slow-release ivermectin implant formulation

    Parasites and Vectors, Vol. 11, Núm. 1

2017

  1. Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae

    Scientific Reports, Vol. 7, Núm. 1

  2. Pilot study of a slow-release ivermectin formulation for malaria control in a pig model

    Antimicrobial Agents and Chemotherapy

2015

  1. Screening for an ivermectin slow-release formulation suitable for malaria vector control

    Malaria Journal, Vol. 14, Núm. 1